Diane L. Fairclough

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

Philip Bonomi, KyungMann Kim, Diane L. Fairclough et al. · Journal of Clinical Oncology · 2000 · 594 citations

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

Jean S. Kutner, Patrick J. Blatchford, Donald H. Taylor et al. · JAMA Internal Medicine · 2015 · 479 citations · Full text

Understanding Economic and Other Burdens of Terminal Illness: The Experience of Patients and Their Caregivers

Ezekiel J. Emanuel, Diane L. Fairclough, Julia Slutsman et al. · Annals of Internal Medicine · 2000 · 437 citations

Differential dropout and bias in randomised controlled trials: when it matters and when it may not

Melanie L. Bell, Michael G. Kenward, Diane L. Fairclough et al. · BMJ · 2013 · 424 citations · Full text

Selection Bias, Health Policy, Medicine +14

Clinicians' Implicit Ethnic/Racial Bias and Perceptions of Care Among Black and Latino Patients

Irene V. Blair, John F. Steiner, Diane L. Fairclough et al. · The Annals of Family Medicine · 2013 · 401 citations · Full text